
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
CenExel Clinical Research, Inc. has announced the creation of their Centers of Excellence company, which unites four clinical research units. The company's goal to design and execute Phase I-IV trials to help pharmaceutical companies improve the time and cost of new therapy development for better patient care.
For more information, click






